Work

Real world characteristics of stages II-III NSCLC patients (pts) who initiate neoadjuvant chemo-immunotherapy (NACT-I) and do not undergo surgical resection.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.8019

Authors: Jair Bar, Giuseppe Domenico Maiocco, Kaushal Parikh, Talia Shentzer Kutiel, Walid Shalata, Sivan Shamai, Mor Moskovitz, Chul Kim, Muskan Agarwal, Alfredo Addeo, Arianna Marinello, Damien Urban, Stanislav Bahlai, Dina Laznik, Idan Tsadok, Hadas Gantz Sorotsky

Institutions: Sheba Medical Center, Mayo Clinic, Rambam Health Care Campus, Soroka Medical Center, Tel Aviv Sourasky Medical Center, Georgetown University, MedStar Georgetown University Hospital, University Hospital of Geneva, Institut Gustave Roussy, Fondation Gustave Roussy, Hadassah Medical Center

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410819611

Cites:

Cited by: 4

Related to: 10